February 20, 2025
ASCO GU Symposium Announces New Findings on Tumor Reduction and Survival Outcomes in Advanced Renal Cell Carcinoma
Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at TTUHSC and director of the UMC Cancer Center, shared groundbreaking findings from the landmark CLEAR study.